The Chemours Company (CC) Financial Statements
The Chemours Company (CC) reported trailing twelve-month revenue of $5.8B (down 0.9% year on year) and net income of -$304.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $218.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CCThe Chemours CompanyFollow CC — free
—
Price chart with a free account
- Market cap
- 1.9B
- P/E TTM
- —
- Dividend yield
- 2.7%
- 52-week
- —
- Next earnings
- 17 Feb, in 116 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.72 | 5.40 | 6.18 | 6.64 | 5.53 | 4.97 | 6.35 | 6.83 | 6.08 | 5.78 | 5.81 | 5.80 | |
| Gross profit | 0.96 | 1.10 | 1.75 | 1.97 | 1.06 | 1.07 | 1.38 | 1.62 | 1.30 | 1.14 | 0.90 | 0.89 | |
| Research & development | 0.10 | 0.08 | 0.08 | 0.08 | 0.08 | 0.09 | 0.11 | 0.12 | 0.11 | 0.11 | 0.11 | 0.11 | |
| Pre-tax income | -0.19 | -0.01 | 0.91 | 1.16 | -0.12 | 0.18 | 0.68 | 0.74 | -0.32 | 0.11 | -0.28 | -0.05 | |
| Income tax | -0.10 | -0.02 | 0.17 | 0.16 | -0.07 | -0.04 | 0.07 | 0.16 | -0.07 | 0.04 | 0.11 | 0.25 | |
| Net income | -0.09 | 0.01 | 0.75 | 1.00 | -0.05 | 0.22 | 0.61 | 0.58 | -0.25 | 0.07 | -0.39 | -0.30 | |
| Diluted EPS ($) | -0.50 | 0.04 | 3.91 | 5.45 | -0.32 | 1.32 | 3.60 | 3.65 | -1.70 | 0.46 | -2.57 | -2.00 | |
| Diluted shares (bn) | 0.181 | 0.183 | 0.191 | 0.183 | 0.165 | 0.166 | 0.169 | 0.158 | 0.149 | 0.150 | 0.150 | — |
USD billions · SEC XBRL
The Chemours Company — questions
- What is The Chemours Company's revenue?
- $5.8B over the twelve months to 2026-06-30, down 0.9% year on year, from its 10-Q and 10-K filings.
- What is The Chemours Company's net income?
- -$304.0M over the twelve months to 2026-06-30.
- What is The Chemours Company's free cash flow?
- $218.0M over the twelve months to 2026-06-30.
- What are The Chemours Company's diluted earnings per share?
- $-2.00 over the twelve months to 2026-06-30.
Every figure on this page comes from The Chemours Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.